The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
What Do Mounjaro Weight Loss Injections Reviews Actually Show?
Mounjaro (tirzepatide) is a prescription-only weekly weight loss injection licensed in the UK. People considering this medication often search for real user experiences and reviews. However, what matters most is what clinical evidence actually shows about effectiveness, side effects, and real-world outcomes. This guide covers what clinical trials revealed, what users typically report, and what to realistically expect from this weight loss injection in the UK.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
What Clinical Trials Show About Mounjaro Effectiveness
The SURMOUNT-1 clinical trial provides the most rigorous evidence available for Mounjaro. At the maximum dose of 15 mg weekly, participants lost an average of 20.9% of their body weight over 72 weeks — significantly more than diet and exercise alone. At 10 mg, average weight loss was 19.5%. Even at lower doses, results were notable: 5 mg showed approximately clinically studied weight loss on average.
These results matter because they're from controlled trials with consistent measurements, not anecdotal reports. However, individual results vary considerably — some participants lost more, others less. The trial involved participants alongside a reduced-calorie diet and increased physical activity, meaning medication was used as a tool alongside lifestyle changes, not instead of them. Weight loss typically appeared after 8–12 weeks and continued over the 72-week study period.
Real-world outcomes in NHS and private practice align broadly with trial data, though individual experiences differ based on dose, adherence, diet quality, and personal physiology.
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
Side Effects and What Users Report Most Commonly
The most frequently reported side effects in clinical trials and real-world use are nausea, diarrhoea, and vomiting, particularly during dose escalation. These often ease over time as the body adjusts. Other common reports include constipation, stomach pain, indigestion, injection site reactions, fatigue, and reduced appetite.
Serious side effects are rare but require immediate medical attention: severe stomach pain (possible pancreatitis), gallbladder problems, serious allergic reactions, or vision changes. Users in online communities frequently mention managing nausea by eating smaller, less fatty meals and staying hydrated. Hair loss is occasionally reported but not confirmed as a direct effect in clinical trials. Weight loss isn't assured — some users plateau despite adherence, which is why your GP or prescriber monitors progress and adjusts doses accordingly.
Use our free BMI calculator above to establish your baseline before starting, and track progress with our free progress tracker as you progress through dose escalation.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
Do real Mounjaro users actually lose the weight shown in trials?
Clinical trials show average weight loss of 15–21% of body weight at higher doses over 72 weeks. Real-world results align broadly with this, but individual outcomes vary significantly based on dose, diet quality, physical activity, adherence, and personal metabolism. Some users achieve better results; others plateau. Weight loss is not assured.
How quickly do people lose weight on Mounjaro?
Weight loss typically begins after 8–12 weeks of treatment. Most significant loss occurs between weeks 8–24. Results continue over 72+ weeks, but the rate of loss may slow. The weekly injection means dose increases happen gradually, so weight loss is gradual and sustained rather than rapid, which is safer and more sustainable.
Are the side effects from Mounjaro reviews typical?
Yes — nausea, diarrhoea, vomiting, and constipation are the most commonly reported side effects in both clinical trials and user reports. These usually occur during dose escalation and often ease over time. Serious side effects are rare. Every person tolerates medication differently, so your experience may differ.
Is Mounjaro weight loss permanent after stopping?
Clinical trial data shows that weight regain occurs after stopping treatment if diet and exercise habits don't change. This is typical for weight loss medications — they're tools to help you lose weight and develop healthier habits, not permanent solutions. Continuing healthy eating and activity patterns is essential.
How does Mounjaro compare to Wegovy based on reviews?
Both are UK-licensed weekly weight loss injections. Mounjaro is a dual GIP and GLP-1 agonist; Wegovy is a GLP-1 agonist only. Mounjaro shows slightly higher average weight loss (15–21% vs Wegovy's ~15%) in trials, but individual results vary. Both require prescription and clinical assessment. Choice depends on prescriber recommendation and individual suitability.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.